There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Unsurprisingly, the patients taking the active semaglutide lost way more weight than their placebo counterparts — but they also experienced dramatic reductions in their pain scales, with an ...

Over 137 million US adults are eligible for semaglutide, mainly for weight loss, diabetes, or cardiovascular prevention. Semaglutide is the top-selling drug in 2023, but affordability remains a ...

Aizen Therapeutics has emerged from stealth with a focus on early-stage programs powered by its novel drug discovery platform, Dax (D-amino acid explorer), a computational protein design model for ...

An article in the June issue (Nat. Biotechnol. 22, 773–774, 2004) highlights the challenge of producing a shared vocabulary that biologists can use to communicate their results effectively ...

Overeating may cause you to feel full, possibly leading to symptoms like abdominal pain, bloating, nausea, acid reflux, sleepiness, and vomiting. What happens if you eat sweets on semaglutide?

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths ...

Does Compounded Semaglutide Work for Weight Loss? Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But it’s important to ...

At week 68, the mean change in the Western Ontario and McMaster Universities Osteoarthritis Index pain score was −41.7 and −27.5 points with semaglutide and placebo, respectively.

We were really focused on using the native sequence for human ... there is a tiny amino acid spacer between the peptide and the fatty acid, whereas with semaglutide there is a whole extra molecule ...